Although it is unclear to which extent the accumulation of galabiosylceramide itself contributes to the renal phenotype of Fabry disease, inhibition of the Gb3S would—in contrast to the inhibition of GCS—eliminate the accumulation not only of globosides but also of galabiosylceramide. The gene discussed is A4GALT; the disease is Fabry disease.